Dr. Cerniglia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Los Angeles, CA 90033
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Hematology and Medical Oncology, 2023 - 2026
Saint Joseph HospitalResidency, Internal Medicine, 2019 - 2022
Georgetown University School of MedicineClass of 2019
Certifications & Licensure
CA State Medical License 2023 - 2025
CO State Medical License 2021 - 2025
Publications & Presentations
PubMed
- 89 citationsAntitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J.L. Wong, Lidia Robert, Mohammad Atefi, Amanda Lassen, Geetha Avarappatt
Molecular Cancer. 2014-08-20 - 272 citationsEffects of MAPK and PI3K Pathways on PD-L1 Expression in MelanomaMohammad Atefi, Earl Avramis, Amanda Lassen, Deborah J.L. Wong, Lidia Robert
Clinical Cancer Research. 2014-07-01 - 64 citationsEffects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma.Amanda Lassen, Mohammad Atefi, Lidia Robert, Deborah Jl Wong, Michael Cerniglia
Molecular Cancer. 2014-04-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
